Illumina, Investor Drop Fight Over Poison Pill In Roche Bid
Gene sequencing company Illumina Inc. and one of its shareholders agreed Monday to resolve the investor's suit, which he had intended to use as an antidote to Illumina's poison pill efforts...To view the full article, register now.
Already a subscriber? Click here to view full article